Bachem Aktie

Bachem für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 914589 / ISIN: CH0012530207

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
23.10.2025 06:39:52

Bachem announces progress in Building K start-up and expansion of its site in Vista, CA

The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan.In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a future capacity expansion at the Vista site, thereby strengthening Bachem’s presence in the US market. Bachem, a leading partner in peptide and oligonucleotide manufacturing, today announced progress in its plans to expand capacity.In Bubendorf, Building K was inspected by the local regulatory authorities (RHI). Based on feedback from the authorities, no delay is expected with regard to the previously communicated development plan for Building K. Bachem continues to expect that production of the first GMP batches can begin in 2025. While the commercial production in the inspected part will be ramped up in 2026, construction work in the remaining part of the building will continue.In Vista, Bachem acquired a property adjacent to its existing facility to add additional upstream and downstream capacity in the future. Bachem will transform the existing property into a production facility. Overall, Bachem plans to invest around USD 250 million over the years 2026 – 2030 in the United States to expand the capacity in Vista and to modernize the Torrance facility. “I’m very pleased with the progress we are making at Bachem with our capacity expansions. We are right on schedule with Building K, which is not only the largest project for Bachem, but also one of the most modern peptide production facilities in the world. Around 350 employees will produce several tons of peptides every year, which will make a significant contribution to healthcare worldwide. In addition, the new property in Vista will enable us to secure additional capacity in the United States, the world’s largest healthcare market and thus will enhance Bachem’s commercial alliances in the Unites States.”Thomas MeierCEO, Bachemin English Download in German Download For more information:Barbora BlahaHead Group CommunicationsTel.: +41 58 595 2021Media: media[at]bachem.comInvestors: ir[at]bachem.comThis publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, “assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Bachem Holding AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Bachem Holding AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments.The post Bachem announces progress in Building K start-up and expansion of its site in Vista, CA appeared first on Bachem.Weiter zum vollständigen Artikel bei Bachem Holding AG

Nachrichten zu Bachem AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Bachem AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!